IMPRiND Project

Post-Brexit scenarios

Regarding the participation of British researchers in Horizon 2020 projects, UK Research and Innovation’s (UKRI) Brussels-based UK Research Office (UKRO) is maintaining and regularly updating a factsheet providing the latest information on the current situation.

If the Withdrawal Agreement is ratified before Brexit, UK participation in Horizon 2020 will be ensured until the end of the programme and for the lifetime of projects.
In the event of a no-deal scenario, different rules will apply depending on whether UK bids to EU calls have been submitted before 31 October 2019 or after.
If UK bids to EU calls have been submitted before 31 October 2019, in case of a no-deal brexit the UK government has committed to guarantee competitive UK bids to EU funding submitted before exit, even if they are notified of their success after exit, for the lifetime of the projects.
If UK bids to EU calls have been submitted after 31 October 2019, the funding for successful UK bids will be guaranteed not by the EU but by UKRI itself, which has been appointed to administer the UK’s guarantee and post-EU exit extension. The funding then will be ensured for the lifetime of such projects, even if they last beyond 2020. The UK government is seeking discussions with the European Commission to agree the details of the UK’s continued participation as a third country.
Source: Swisscore, UKRI

Interview of Benjamin Falcon on Neuronet

An interview of Benjamin Falcon (LMB team) entitled "Spotlight on early-career investigators: an interview with Benjamin Falcon" was published this month on Neuronet, the European network on Neurodegeneration research.

NEURONET website launched

We are pleased to announce that the NEURONET Coordination and Support Action on neurodegeneration research launches its website.

NEURONET is a three-year coordination and support action that kicked off in March 2019. The aim of NEURONET is to set up an efficient platform to boost collaboration across research projects focusing on neurodegenerative diseases, including but not limited to Alzheimer’s disease.

Enjoy browsing this new site which also links to a network of existing IMI projects in the field, amongst which IMPRiND is proud to be.

IMPRiND member Michel Goedert is awarded the Royal medal

Congratulations! IMPRiND consortium member Michel Goedert @MichelGoed is awarded the 2019 Royal Medal for Biological Sciences.

Michel has been honoured for his work on neurodegenerative diseases, especially for identifying and characterising key molecules that form the inclusions of Alzheimer’s and Parkinson’s diseases which he also carries out in the frame of the IMPRiND project.

More information can be found on the website of the MRC Laboratory of Molecular Biology (LMB).

Cool structures from IMPRiND partner CNRS published in bioRxiv

On May 30 a paper by Luc Bousset and Ronald Melki on two new polymorphic structures of alpha-synuclein solved by cryo-electron microscopy was published in bioRxiv. Access to the article.

Show more posts

This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.